TerminatedNot Applicable

MISP 60528 Pneumococcal Vaccination

Stopped: Termination of funding by the sponsor/funder.

United States4 participantsStarted 2021-06-10

Plain-language summary

This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 or over * Either undergoing evaluation for heart transplant (with or without LVAD receipt), or having received a heart transplant * Receiving a dose of PCV15 or PPSV23 (or both sequentially) concordant with AST guidelines Exclusion Criteria: * Infants and children under age 18 * Subjects without the capacity to consent * Pregnancy * Already up to date on pneumococcal vaccination or declining vaccination

What they're measuring

Vaccine response

Timeframe: 12 weeks

Trial details

NCT IDNCT04845945

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-24

View on ClinicalTrials.gov More Heart Transplant Infection Prevention trials